HomeACQUISITIONS and MERGERS
ACQUISITIONS and MERGERS
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
Agilent Technologies to Acquire North American CDMO BIOVECTRA
BIOVECTRA and Agilent Technologies are fully integrated CDMOs with state-of-the-art facilities that follow current Good Manufacturing Practices (cGMP), a high standard for methods, facilities, and controls used in manufacturing, processing, and packaging of active pharmaceutical ingredients.
Grünenthal Acquires US-company Valinor Pharma and Becomes Global Owner of Movantik®
"As a pain specialist, Movantik is a perfect fit for Grünenthal with our existing customer base and complementary product portfolio", says Gabriel Baertschi, CEO, Grünenthal. "The acquisition of Valinor Pharma strengthens our footprint in the United States, the most important growth market for Grünenthal."
Meitheal Pharmaceuticals Expands Specialty Biopharmaceuticals Portfolio with Acquisition of CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics
Under the Asset Purchase Agreement, Meitheal Pharmaceuticals acquires North America rights to CONTEPO™, including any results of development and regulatory activities, and all intellectual property (IP) rights, technology, and know-how related to CONTEPO™. In exchange, Nabriva will receive payment upon closing and a royalty on net U.S. sales of CONTEPO™.
Zensar Technologies Acquires BridgeView Life Sciences to Boost Healthcare and Life Sciences Focus
Zensar Technologies notes this strategic move strengthens Zensar's Healthcare and Life Sciences (HLS) vertical and expands its pharma commercial and product launch expertise.
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care
"We are thrilled to welcome Volpara into the Lunit family. Today, we take a monumental step towards revolutionizing our approach to cancer care. By combining our strengths, we are creating a formidable alliance in the industry, particularly in the US market. This merger enables us to develop and deliver innovative, life-saving solutions that meet critical needs in cancer diagnostics," said Brandon Suh, CEO of Lunit.
Johnson & Johnson to Acquire Shockwave Medical
The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and accelerates its shift into higher-growth markets.
Owen Mumford Acquires Empelvic
“The acquisition of Empelvic reinforces our commitment to comprehensive health solutions for intimate conditions,” said Adam Mumford, Director of Medical Devices at Owen Mumford. “By combining Owen Mumford's global expertise with Empelvic's innovative product, we aim to provide enhanced support and choices for individuals seeking pelvic health solutions.”
ACU-Serve Acquires Beyond HME, Paving the Way for Strategic Expansion
"The acquisition of Beyond HME represents a pivotal moment for ACU-Serve as we continue to pursue strategic growth opportunities in the healthcare sector," said Jim Knight, President of ACU-Serve. "Beyond HME's reputation for excellence and its focus on re-supply services complement our existing offerings, positioning us for even greater success in meeting the evolving needs of our clients."
Avant Technologies Enters into Negotiations to Acquire Key Player in Healthcare Data Interoperability Services
Avant Technologies CEO Timothy Lantz: “We are excited about this opportunity to accelerate Avant’s growth within the healthcare sector and create new value for our customers and shareholders. This acquisition will serve to further strengthen our financial position, unlock new growth opportunities in one of the top segments of AI adoption, and bolster our internal product development and client services capabilities.”
Recent News
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants
"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting
This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”